JP2015034182A5 - - Google Patents

Download PDF

Info

Publication number
JP2015034182A5
JP2015034182A5 JP2014232639A JP2014232639A JP2015034182A5 JP 2015034182 A5 JP2015034182 A5 JP 2015034182A5 JP 2014232639 A JP2014232639 A JP 2014232639A JP 2014232639 A JP2014232639 A JP 2014232639A JP 2015034182 A5 JP2015034182 A5 JP 2015034182A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
integer
mol
polyorthoester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014232639A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015034182A (ja
JP6057972B2 (ja
Filing date
Publication date
Priority claimed from US10/953,841 external-priority patent/US20050042194A1/en
Application filed filed Critical
Publication of JP2015034182A publication Critical patent/JP2015034182A/ja
Publication of JP2015034182A5 publication Critical patent/JP2015034182A5/ja
Application granted granted Critical
Publication of JP6057972B2 publication Critical patent/JP6057972B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2014232639A 2004-09-28 2014-11-17 半固体送達賦形剤および薬学的組成物 Expired - Lifetime JP6057972B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/953,841 2004-09-28
US10/953,841 US20050042194A1 (en) 2000-05-11 2004-09-28 Semi-solid delivery vehicle and pharmaceutical compositions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012045876A Division JP2012107064A (ja) 2004-09-28 2012-03-01 半固体送達賦形剤および薬学的組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016203588A Division JP2017008113A (ja) 2004-09-28 2016-10-17 半固体送達賦形剤および薬学的組成物

Publications (3)

Publication Number Publication Date
JP2015034182A JP2015034182A (ja) 2015-02-19
JP2015034182A5 true JP2015034182A5 (enExample) 2015-04-09
JP6057972B2 JP6057972B2 (ja) 2017-01-11

Family

ID=36119607

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007533786A Withdrawn JP2008514646A (ja) 2004-09-28 2005-09-27 半固体送達賦形剤および薬学的組成物
JP2012045876A Withdrawn JP2012107064A (ja) 2004-09-28 2012-03-01 半固体送達賦形剤および薬学的組成物
JP2014232639A Expired - Lifetime JP6057972B2 (ja) 2004-09-28 2014-11-17 半固体送達賦形剤および薬学的組成物
JP2016203588A Pending JP2017008113A (ja) 2004-09-28 2016-10-17 半固体送達賦形剤および薬学的組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2007533786A Withdrawn JP2008514646A (ja) 2004-09-28 2005-09-27 半固体送達賦形剤および薬学的組成物
JP2012045876A Withdrawn JP2012107064A (ja) 2004-09-28 2012-03-01 半固体送達賦形剤および薬学的組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016203588A Pending JP2017008113A (ja) 2004-09-28 2016-10-17 半固体送達賦形剤および薬学的組成物

Country Status (10)

Country Link
US (10) US20050042194A1 (enExample)
EP (4) EP2902012B1 (enExample)
JP (4) JP2008514646A (enExample)
KR (1) KR20070083851A (enExample)
CN (1) CN101052376A (enExample)
AU (1) AU2005289425A1 (enExample)
CA (1) CA2579297A1 (enExample)
ES (1) ES2529574T3 (enExample)
TW (1) TWI407966B (enExample)
WO (1) WO2006037116A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050042194A1 (en) * 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
DK2767292T3 (en) * 2004-09-17 2016-12-19 Durect Corp RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20070264338A1 (en) * 2006-05-12 2007-11-15 Shah Devang T Base-stabilized polyorthoester formulations
US20070264339A1 (en) * 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations
US20070265329A1 (en) * 2006-05-12 2007-11-15 Devang Shah T Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
FR2901702A1 (fr) * 2006-05-31 2007-12-07 Galderma Res & Dev S N C Snc Utilisation de granisetron pour le traitement de sous-types de la rosacee, et compositions pharmaceutiques
EP2044142A2 (en) 2006-06-29 2009-04-08 Medtronic, Inc. Poly(orthoester) polymers, and methods of making and using same
EP1917971A1 (en) * 2006-10-27 2008-05-07 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Substained release formulations comprising very low molecular weight polymers
EP2484347A1 (en) 2006-11-03 2012-08-08 Durect Corporation Transdermal delivery systems comprising bupivacaine
WO2009075782A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US8475823B2 (en) * 2008-04-18 2013-07-02 Medtronic, Inc. Baclofen formulation in a polyorthoester carrier
US8956642B2 (en) * 2008-04-18 2015-02-17 Medtronic, Inc. Bupivacaine formulation in a polyorthoester carrier
CN103550847A (zh) * 2008-04-28 2014-02-05 佐吉尼克斯股份有限公司 用于治疗偏头痛的新制剂
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US20100120811A1 (en) * 2008-07-17 2010-05-13 Peter Hanson Long-acting injectable analgesic formulations for animals
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
TWI372057B (en) * 2008-12-11 2012-09-11 Dev Center Biotechnology Sustained release implant for granisetron
CN102292076A (zh) * 2008-12-11 2011-12-21 阿帕医药有限公司 增强聚原酸酯及其制剂的稳定性的方法
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
US9849180B2 (en) 2014-09-15 2017-12-26 Hui Rong Shen Long-acting semi-solid lipid formulations
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
MX352907B (es) * 2013-03-15 2017-12-13 Heron Therapeutics Inc Composiciones de un poliortoéster y un solvente aprótico.
US20140323517A1 (en) * 2013-04-30 2014-10-30 Heron Therapeutics, Inc. Compositions and methods for injection of a biodegradable polymer-based delivery system
CA2924231C (en) 2013-10-07 2018-04-03 Teikoku Pharma Usa, Inc. Dexmedetomidine transdermal delivery devices and methods for using the same
CN106456561B (zh) 2013-10-07 2020-02-28 帝国制药美国公司 使用右旋美托咪啶经皮组合物治疗注意力缺陷多动症、焦虑症和失眠症的方法和组合物
KR20180095732A (ko) 2013-10-07 2018-08-27 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
BR112016024665B1 (pt) * 2014-04-21 2023-04-11 Heron Therapeutics, Inc Composição, composição semissólida e seu uso
US11083730B2 (en) 2014-04-21 2021-08-10 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
EP3134070B1 (en) * 2014-04-21 2020-09-23 Heron Therapeutics, Inc. Compositions of a polyorthoester and an organic acid excipient
US9801945B2 (en) 2014-04-21 2017-10-31 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
MY205229A (en) 2016-07-06 2024-10-08 Durect Corp Oral dosage form with drug composition, barrier layer and drug layer
CN107789628B (zh) * 2016-12-29 2021-07-23 天津键凯科技有限公司 一种聚乙二醇和局部麻醉药的结合物在非麻醉镇痛中的应用
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11162850B2 (en) 2019-04-25 2021-11-02 Measurement Specialties, Inc. Sensor assemblies with integrated electrical connections and diaphragm overload protection
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CN113980254A (zh) * 2020-07-10 2022-01-28 南京泛太化工医药研究所 一种具有酸敏感降解、温敏性质的系列聚合物及其载药组合物
CN116940358A (zh) 2021-01-12 2023-10-24 度勒科特公司 持续释放药物递送系统和有关的方法
AU2022343289A1 (en) * 2021-09-09 2024-02-29 Xeris Pharmaceuticals, Inc. Injectable high concentration pharmaceutical formulations and methods of manufacturing and use thereof
CN114366711A (zh) * 2021-12-09 2022-04-19 安徽大学 原酸酯混溶物药用辅料、制备方法、包含该辅料的局部缓释给药制剂
JP2025528954A (ja) * 2022-01-20 2025-09-02 ナンジン ファンタイ ケミカル ファーマシューティカル リサーチ インスティテュート 酸感受性分解性および温度感受性を有する一連のポリマーおよびその薬物担持組成物

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179497A (en) * 1973-12-17 1979-12-18 Merck & Co., Inc. Solid state ophthalmic medication
US4180646A (en) * 1975-01-28 1979-12-25 Alza Corporation Novel orthoester polymers and orthocarbonate polymers
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4131648A (en) * 1975-01-28 1978-12-26 Alza Corporation Structured orthoester and orthocarbonate drug delivery devices
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4098709A (en) * 1975-12-11 1978-07-04 Rohm And Haas Company Polymeric antioxidant viscosity index improvers
US4079038A (en) * 1976-03-05 1978-03-14 Alza Corporation Poly(carbonates)
US4304767A (en) * 1980-05-15 1981-12-08 Sri International Polymers of di- (and higher functionality) ketene acetals and polyols
US4322323A (en) * 1980-12-01 1982-03-30 Alza Corporation Erodible device comprising surfactant for modifying the rate of erosion of the device
PT75625B (en) 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
US4532335A (en) * 1983-03-07 1985-07-30 Sri International Preparation of ketene acetals by rearrangement of allyl and substituted allyl acetals
GB8416234D0 (en) * 1984-06-26 1984-08-01 Ici Plc Biodegradable amphipathic copolymers
US4549010A (en) * 1984-06-27 1985-10-22 Merck & Co., Inc. Bioerodible poly(ortho ester) thermoplastic elastomer from diketene diacetal
US4946931A (en) * 1989-06-14 1990-08-07 Pharmaceutical Delivery Systems, Inc. Polymers containing carboxy-ortho ester and ortho ester linkages
FI98367C (fi) * 1989-11-28 1997-06-10 Syntex Inc Menetelmä uusien terapeuttisesti käyttökelpoisten trisyklisten, typpipitoisten yhdisteiden valmistamiseksi
NZ239370A (en) 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
MX9200038A (es) 1991-01-09 1992-11-01 Alza Corp Dispositivos biodegradables y composiciones para la liberacion por difusion de agentes.
US5929059A (en) * 1991-01-19 1999-07-27 Smithkline Beecham P.L.C. Pharmaceutical compositions containing granisetron and dexamethasone
US5211951A (en) * 1991-07-24 1993-05-18 Merck & Co., Inc. Process for the manufacture of bioerodible poly (orthoester)s and polyacetals
ZA932272B (en) * 1992-03-30 1993-10-19 Alza Corp Viscous suspensions of controlled-release drug particles
EP0633907A1 (en) 1992-03-30 1995-01-18 Alza Corporation Additives for bioerodible polymers to regulate degradation
WO1993024476A1 (en) * 1992-06-04 1993-12-09 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
US5922340A (en) * 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
MY113268A (en) * 1992-12-29 2002-01-31 Insite Vision Incorporated Plasticized bioerodible controlled delivery system
ATE194489T1 (de) 1992-12-29 2000-07-15 Insite Vision Inc Bioerodierbares system zur kontrollierten freigabe
DK1125577T3 (da) * 1994-04-08 2006-06-19 Qlt Usa Inc Væskeformige medikamentindföringspræparater
GB9412995D0 (en) * 1994-06-28 1994-10-26 Prendergast Kenneth F Safety enhancing pharmaceutical compositions of an active indazole
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5607686A (en) * 1994-11-22 1997-03-04 United States Surgical Corporation Polymeric composition
US5968543A (en) * 1996-01-05 1999-10-19 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
CA2242631C (en) 1996-01-05 2008-09-09 Advanced Polymer Systems, Inc. Polymers with controlled physical state and bioerodibility
US5690059A (en) * 1996-04-16 1997-11-25 Woods; Jeff Training collar
FR2748364B1 (fr) * 1996-05-09 1998-07-31 Kuhn Sa Broyeur de vegetaux perfectionne quant a sa faculte d'adaptation au relief du sol
BR9709915A (pt) 1996-06-21 1999-08-10 Merck Sharp & Dohme Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto
US6046187A (en) * 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
CA2219698C (en) * 1996-10-31 2007-09-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
AU3170697A (en) 1997-05-30 1998-12-30 Minnesota Mining And Manufacturing Company Transdermal drug delivery device for the delivery of tropisetron or granisetron
US6103266A (en) * 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
US5939453A (en) 1998-06-04 1999-08-17 Advanced Polymer Systems, Inc. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
GB9813576D0 (en) 1998-06-24 1998-08-19 Merck Sharp & Dohme Therapeutic agents
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6613355B2 (en) * 2000-05-11 2003-09-02 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
US20050042194A1 (en) 2000-05-11 2005-02-24 A.P. Pharma, Inc. Semi-solid delivery vehicle and pharmaceutical compositions
AU2001261516A1 (en) * 2000-05-11 2001-11-20 Advanced Polymer Systems Inc. Semi-solid delivery vehicle and pharmaceutical compositions
MXPA03000277A (es) 2000-07-18 2004-04-05 Leo Pharma As Inhibidores de metaloproteinasa de matriz.
KR100446101B1 (ko) * 2000-12-07 2004-08-30 주식회사 삼양사 수난용성 약물의 서방성 제형 조성물
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20020176844A1 (en) * 2001-05-11 2002-11-28 Ng Steven Y. Bioerodible polyorthoesters containing hydrogen bonding groups
FR2826280B1 (fr) * 2001-06-20 2005-03-04 Ceva Sante Animale Composition semi-solide injectable biodegradable assurant un profil de liberation particulier
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
JP2006503004A (ja) * 2002-07-31 2006-01-26 アルザ・コーポレーション 射出可能なデポ組成物及びその使用
DK1539101T3 (da) * 2002-07-31 2009-04-27 Alza Corp Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
CN1713890A (zh) * 2002-11-06 2005-12-28 阿尔萨公司 控释储库制剂
US7045589B2 (en) * 2002-11-15 2006-05-16 A.P. Pharma, Inc. Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
US20050096365A1 (en) * 2003-11-03 2005-05-05 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
WO2006105148A2 (en) * 2005-03-31 2006-10-05 Ap Pharma, Inc. Peg-poly(ortho ester) graft copolymers and pharmaceutical compositions
JP2008534747A (ja) * 2005-03-31 2008-08-28 エーピー ファーマ， インコーポレイテッド Ｐｅｇ−ポリアセタールグラフトコポリマーおよびｐｅｇ−ポリアセタール−ｐｏｅグラフトコポリマーならびに医薬組成物
US20070264339A1 (en) 2006-05-12 2007-11-15 Ap Pharma, Inc. Base-stabilized polyorthoester formulations

Similar Documents

Publication Publication Date Title
JP2015034182A5 (enExample)
JP2015522001A5 (enExample)
JP2016516062A5 (enExample)
NZ628828A (en) Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease
RU2015117539A (ru) Диагностика, профилактика и лечение болезней суставов
JP2019501133A5 (enExample)
JP2017039758A (ja) 生分解性薬物送達組成物
JP2015520184A5 (enExample)
JP2013511496A5 (enExample)
IN2012DN00407A (enExample)
AR058866A1 (es) Un polimero biocompatible, no biodegradable, no toxico, util para composiciones farmaceuticas en nanoparticulas
RU2016139373A (ru) Растворы бупренорфина с замедленным высвобождением
JP2016531895A5 (enExample)
JP2014515407A5 (enExample)
SA517381298B1 (ar) تركيبة صيدلية بثبات محسن
JP2014518272A5 (enExample)
JP2011500781A5 (enExample)
JP2019537589A5 (enExample)
US10980886B2 (en) Compositions of a polyorthoester and an organic acid excipient
JP2016530316A5 (enExample)
JP2012503602A5 (enExample)
ES2813856T3 (es) Solución antiinfecciosa que comprende un compuesto pirido(3,2,1-ij-benzoxadiazina
US10426727B2 (en) Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs
JP2007515425A (ja) 医薬組成物
US20170100336A1 (en) Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs